“It’s time that Europe makes up for lost ground in biopharmaceutical innovation”

11:18 Farmaindustria
Farmaindustria hosts a meeting which brought together over twenty members of National Associations in Europe representing innovative pharmaceutical industry and EFPIA, along with the Spanish Medicines Agency, to debate how regulation can boost pharmaceutical innovation in the European Union.

Juan Yermo, Director General of Farmaindustria, stressed the opportunity presented by the Spanish Presidency of the Council of the EU in the second half of 2023 to include the research-based pharmaceutical industry among the priorities of its mandate.

María Jesús Lamas, Director of the Spanish Medicines Agency’s, emphasized that the European Commission’s revision of the current EU regulatory framework for pharmaceuticals should serve as an opportunity for Europe to recover its leading role in biopharmaceutical research.

The pharmaceutical industry advocates for collaboration with other healthcare stakeholders to achieve new advances in health

10:00 Farmaindustria
The international federation of the research-based pharmaceutical industry, IFPMA, has renewed its commitment to global health progress in celebration of its 50th anniversary

The pharmaceutical industry can claim several examples of success in recent decades such as vaccines, the fight against HIV and cancer and also the cure for Hepatitis C

In Spain, almost half of the €1,100 million that the pharmaceutical industry invests in R&D is dedicated to collaboration projects with centres and external parties

The pharmaceutical industry generates 200,000 jobs in Spain, of which 37,000 are direct positions

12:11 Farmaindustria
Research, talent, transparency and collaboration are the key elements of the sector
Logo de Pacto Digital para la Protección de las Personas
Logo de Pacto Digital para la Protección de las Personas

© 2024 FarmaIndustria All rights reserved